Please assess the completion status of the following clinical trial:

Trial Title: Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Adult patients over 18 years old with diabetes (both sexes) presenting without any kidney disease or with ESRD on hemodialysis~* Undergoing major elective surgery procedures such as abdominal, pulmonary, GU/GYN, vascular, renal, neurologic, and orthopedic surgery~* Signed informed consent for the study.~* Patients with elevated preoperative blood glucose of a value \> 150 mg/dL or \< 350 mg/dL~* English-speaking~* Baseline chemistry with a potassium at or above 3.5~Exclusion criteria:~* Patients under the age of 18.~* Pregnant women. (Pregnant women have altered glucose metabolism; specific insulin regimen used for pregnant women)~* Patient does not give informed consent for the study.~* Patient does not have decisional capacity or a surrogate.~* Patient cannot understand or read English.~* Patients with a preoperative blood glucose \< 150 mg/dL or \>350 mg/dL~* Patients without diabetes~* Patients with kidney disease that are not on hemodialysis~* A history of frequent hypoglycemia in the month prior to surgery by history or a change in insulin dose for hypoglycemia in the month prior to surgery~* Patients taking steroids or patients that will receive steroids during their surgery~* Any patients who refuse to remain NPO except water in the two hour window after their last insulin dose~* Patients scheduled for cardiac, thoracic and emergency surgeries~* Patients who have taken or received insulin or oral hypoglycemic agents after 12 am on the day of surgery.~* Patients have not adhered to the NPO status.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Patients with diabetes and ESRD (Type: OTHER): Patients with diabetes and end stage renal disease (ESRD)
- Patients with diabetes and no ESRD (Type: OTHER): Patients with diabetes and no end stage renal disease (ESRD)

Based on this trial design, predict the completion outcome and termination type (if applicable).